Additionally, a dysregulation of the renin–angiotensin system (RAS) pathway has been observed [69] with increased angiotensin-converting enzyme (ACE) activity and higher levels of angiotensin II and aldosterone especially in OSA patients with pre-existing hypertension [70]. This evidence concerns the gene ACE and hypertensive disorder.